Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5012 Tacrine-pyrimidone Hybrid 27g
Novel Potent Dual AChE/GSK-3 Inhibitor for the Treatment of Alzheimers Disease
More description
DCC5011 Tachyplegina-4
Novel Irriversible Inhibitor of Parasite Motility and Invasion
More description
DCC5010 Tachyplegina-2
Novel Inhibitor of Parasite Motility and Invasion
More description
DCC5009 Tachyplegina
Novel Inhibitor of Parasite Motility and Invasion
More description
DCC5008 Tachioside
Natural radical scavenger on ABTS
More description
DCC5007 T6603185
Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems
More description
DCC5006 T5975164
Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein
More description
DCC5005 t5660138
Novel Inhibitor of Adenovirus Gene Transfer
More description
DCC5004 t5660136
Novel Inhibitor of Adenovirus Gene Transfer
More description
DCC5003 T3ss Inhibitor Iii-7
Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)
More description
DCC5002 T-2 Toxin Triol
Type-A trichothecene mycotoxin
More description
DCC5001 T16a(inh)-d01
Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)
More description
DCC5000 T16a(inh)-b01
Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)
More description
DCC4999 T-10106
Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile
More description
DCC4998 T-0632
Potent and selective CCKA receptor antagonist
More description
DCC4997 T0511-4424
Novel COX-2 inhibitor
More description
DCC4996 Szv558
Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD
More description
DCC4994 Synthalin Dihydrochloride
K+ channel blocker
More description
DCC4993 Synstab A
Novel microtubule-stablizer
More description
DCC4992 syn22269076
Novel Mycobacterium tuberculosis growth inhibitor
More description
DCC4991 Syn-1 Scr Peptide
Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence
More description
DCC4990 Syn-1 Peptide
Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml
More description
DCC4989 Syk-in-ii
Novel inhibitor of the Syk kinase (spleen tyrosine kinase)
More description
DCC4988 Syk-524
Novel universal opioid receptor agonist
More description
DCC4987 Sy-5609
Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo
More description
DCC4986 S-y048
Novel selective OXE receptor antagonist
More description
DCC4985 swertisin
Potent differentiating agent
More description
DCC4984 Swainsonine
Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities
More description
DCC4983 Sw208108
Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)
More description
DCC4982 Sv-iii-130s
D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X